Hide metadata

dc.date.accessioned2021-12-10T13:08:12Z
dc.date.available2021-12-10T13:08:12Z
dc.date.created2021-11-19T11:18:35Z
dc.date.issued2021
dc.identifier.citationKleive, Dyre Aas, Eline Angelsen, Jon-Helge Bringeland, Erling Audun Nesbakken, Arild Nymo, Linn Såve Schultz, Johannes Kurt Søreide, Kjetil Yaqub, Sheraz . Simultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gaps. Oncology and Therapy. 2021, 9(11)
dc.identifier.urihttp://hdl.handle.net/10852/89492
dc.description.abstractThe timing of surgical resection of synchronous liver metastases from colorectal cancer has been debated for decades. Several strategies have been proposed, but high-level evidence remains scarce. Simultaneous resection of the primary tumour and liver metastases has been described in numerous retrospective audits and meta-analyses. The potential benefits of simultaneous resections are the eradication of the tumour burden in one procedure, overall shorter procedure time, reduced hospital stay with the likely benefits on quality of life and an expected reduction in the use of health care services compared to staged procedures. However, concerns about accumulating complications and oncological outcomes remain and the optimal selection criteria for whom simultaneous resections are beneficial remains undetermined. Based on the current level of evidence, simultaneous resection should be restricted to patients with a limited liver tumour burden. More high-level evidence studies are needed to evaluate the quality of life, complication burden, oncological outcomes, as well as overall health care implications for simultaneous resections.
dc.languageEN
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleSimultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gaps
dc.typeJournal article
dc.creator.authorKleive, Dyre
dc.creator.authorAas, Eline
dc.creator.authorAngelsen, Jon-Helge
dc.creator.authorBringeland, Erling Audun
dc.creator.authorNesbakken, Arild
dc.creator.authorNymo, Linn Såve
dc.creator.authorSchultz, Johannes Kurt
dc.creator.authorSøreide, Kjetil
dc.creator.authorYaqub, Sheraz
cristin.unitcode185,52,11,0
cristin.unitnameAvdeling for helseledelse og helseøkonomi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1956365
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Oncology and Therapy&rft.volume=9&rft.spage=&rft.date=2021
dc.identifier.jtitleOncology and Therapy
dc.identifier.volume9
dc.identifier.issue1
dc.identifier.startpage111
dc.identifier.endpage120
dc.identifier.pagecount10
dc.identifier.doihttps://doi.org/10.1007/s40487-021-00148-2
dc.identifier.urnURN:NBN:no-92106
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2366-1070
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/89492/1/Kleive2021_Article_SimultaneousResectionOfPrimary.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International